Advertisement

Decision soon on Covid-19 vaccine availability in Pak: NCOC

Follow The Hawk on Google News+ Follow

Advertisement


Islamabad: Pakistan's National Command and Operation Centre (NCOC) has announced that the federal government will soon make a decision about the availability of a vaccine against the novel coronavirus in the country at the earliest.

In a statement on Wednesday, the NCOC said the government was regularly reviewing developments taking place around the globe, including data from phase 3 trials, reports Dawn news.

Advertisement

"These steps will lead to a final decision about early availability of the vaccine in Pakistan," it said.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

On Wednesday, the country reported 2,142 new Covid-19 cases with 84 fatalities, which increased the overall infection tally and death toll to 465,070 and 9,558, respectively.

University of Health Sciences Vice Chancellor and Scientific Task Force on Covid-19 member Javed Akram disclosed that 15,000 people, 80 per cent of the total volunteers, had been administered Chinese vaccine expressing the hope that the trial would end in December.

Advertisement

In Pakistan, the clinical trial of the Chinese vaccine began in September with the initial sample size of 10,000 volunteers.

Also read'Fatty liver-free campaign' in Ranchi from Nov 23, MoS Sanjay Seth to take lead

However, the number was enhanced to 18,000 later.

The vaccine is ribonucleic acid based and will generate antibodies against the spikes as a result of which the virus will not be able to attach itself to lungs.

—IANS

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST